Free Trial

Digital Health Acquisition (DHAC) Competitors

Digital Health Acquisition logo
$1.19 +0.04 (+3.75%)
As of 04/17/2025

DHAC vs. BRTX, MGRX, KDLY, SSY, OTRK, ACON, BGLC, ATIP, VSEE, and NIVF

Should you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), Kindly MD (KDLY), SunLink Health Systems (SSY), Ontrak (OTRK), Aclarion (ACON), BioNexus Gene Lab (BGLC), ATI Physical Therapy (ATIP), Vsee Health (VSEE), and NewGenIvf Group (NIVF). These companies are all part of the "healthcare" industry.

Digital Health Acquisition vs.

Digital Health Acquisition (NASDAQ:DHAC) and BioRestorative Therapies (NASDAQ:BRTX) are both small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, community ranking, earnings, profitability and institutional ownership.

Digital Health Acquisition has higher earnings, but lower revenue than BioRestorative Therapies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
BioRestorative Therapies$401K32.00-$14.41M-$1.16-1.47

In the previous week, BioRestorative Therapies had 1 more articles in the media than Digital Health Acquisition. MarketBeat recorded 2 mentions for BioRestorative Therapies and 1 mentions for Digital Health Acquisition. BioRestorative Therapies' average media sentiment score of 0.70 beat Digital Health Acquisition's score of 0.00 indicating that BioRestorative Therapies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Digital Health Acquisition
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioRestorative Therapies
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BioRestorative Therapies has a consensus target price of $18.00, indicating a potential upside of 952.63%. Given BioRestorative Therapies' stronger consensus rating and higher possible upside, analysts plainly believe BioRestorative Therapies is more favorable than Digital Health Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Digital Health Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BioRestorative Therapies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Digital Health Acquisition has a net margin of 0.00% compared to BioRestorative Therapies' net margin of -2,697.08%. Digital Health Acquisition's return on equity of 0.00% beat BioRestorative Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
BioRestorative Therapies -2,697.08%-98.49%-75.23%

BioRestorative Therapies received 2 more outperform votes than Digital Health Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Digital Health AcquisitionN/AN/A
BioRestorative TherapiesOutperform Votes
2
100.00%
Underperform Votes
No Votes

Digital Health Acquisition has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Comparatively, BioRestorative Therapies has a beta of 68.9, suggesting that its stock price is 6,790% more volatile than the S&P 500.

1.0% of Digital Health Acquisition shares are owned by institutional investors. Comparatively, 69.4% of BioRestorative Therapies shares are owned by institutional investors. 6.6% of Digital Health Acquisition shares are owned by insiders. Comparatively, 25.5% of BioRestorative Therapies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

BioRestorative Therapies beats Digital Health Acquisition on 10 of the 13 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAC vs. The Competition

MetricDigital Health AcquisitionHolding Offices Industry SectorNASDAQ Exchange
Market Cap$4.30M$452.08M$2.30B$7.15B
Dividend YieldN/A8.11%13.24%4.34%
P/E RatioN/A2.3910.8217.51
Price / SalesN/A56.593,222,777.2296.22
Price / CashN/A69.0157.1134.62
Price / BookN/A3.653.273.91
Net IncomeN/A$34.68M-$322.08M$247.19M
7 Day Performance14.06%0.63%-1.24%-0.12%
1 Month Performance-1.40%-0.29%-4.98%-8.12%
1 Year Performance-90.06%11.20%1.72%-1.31%

Digital Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAC
Digital Health Acquisition
N/A$1.19
+3.7%
N/A-90.1%$4.30MN/A0.002,021
BRTX
BioRestorative Therapies
3.579 of 5 stars
$1.75
-2.0%
$18.00
+931.5%
+24.8%$13.10M$401,000.00-1.147Short Interest ↓
MGRX
Mangoceuticals
0.3106 of 5 stars
$2.11
+5.6%
N/A-96.2%$10.92M$615,873.00-0.363Negative News
KDLY
Kindly MD
0.2213 of 5 stars
$1.63
-4.1%
N/AN/A$9.83M$2.72M-2.47N/APositive News
SSY
SunLink Health Systems
N/A$0.89
-5.3%
N/A+37.9%$6.27M$31.23M6.361,376Analyst Forecast
News Coverage
OTRK
Ontrak
2.6237 of 5 stars
$1.37
-8.7%
$45.00
+3,184.7%
-62.0%$5.78M$11.24M-0.13250Earnings Report
Short Interest ↓
ACON
Aclarion
2.3023 of 5 stars
$9.21
+0.8%
$11,758.50
+127,571.0%
-99.7%$5.36M$49,289.000.007Gap Up
BGLC
BioNexus Gene Lab
0.6422 of 5 stars
$2.82
+6.4%
N/A-55.5%$5.07M$9.26M0.0030Gap Down
ATIP
ATI Physical Therapy
N/A$1.00
+23.8%
N/A-75.2%$4.41M$741.86M-0.055,600Gap Down
VSEE
Vsee Health
1.6064 of 5 stars
$1.18
+10.3%
$5.00
+323.8%
N/A$4.25M$6.38M0.00N/A
NIVF
NewGenIvf Group
1.5674 of 5 stars
$0.37
-9.1%
N/A-98.2%$1.92M$5.14M0.00N/AShort Interest ↓
Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:DHAC) was last updated on 4/22/2025 by MarketBeat.com Staff
From Our Partners